Morphic Medical strengthens board with veteran

Morphic Medical, developer of a novel device targeting type 2 diabetes, has appointed healthcare veteran Terri Cooper to its board of directors. Cooper's extensive experience in the healthcare industry is expected to provide valuable strategic guidance as the company advances its innovative medical technology. This appointment signifies Morphic Medical's commitment to strengthening its leadership team to support its mission of addressing the underlying causes of type 2 diabetes and expanding its market reach.